Interdisciplinary cooperation between LMU and Helmholtz Munich supported by Bavarian Research Foundation
Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that…
In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence. A team from Helmholtz Munich is laying the foundations for this.
Helmholtz Munich researcher Dr Vincent Fortuin is one of the young investigator group leaders at Helmholtz AI. His work focuses on the interface between Bayesian inference and deep learning. Bayesian inference is a statistical method to learn from…
Every year, the Bayer Foundation awards the Early Excellence in Science Award. This year’s winner in the category “Data Science in the Life Sciences” is Helmholtz Munich researcher Mohammad Lotfollahi from the Institute of Computational Biology. With…
Helmholtz Munich researcher Carsten Marr, Director of the Institute of AI for Health, has acquired a European Research Council (ERC) Proof of Concept Grant for his project on the development of LeukoScreen, an AI-based software to automatically…
The SARS-CoV-2 pandemic has challenged public health worldwide. The European project ORCHESTRA - Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic - was launched in December 2020 to unite European knowledge…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
